Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 04, 2019
Source ID
10.1007/s10549-019-05307-8

Entities

People

  • Albert J. Kovatich
  • Amit Joshi
  • Amy R. Peck
  • Angela Lemke
  • Caitlin O’meara
  • Carmen Bergom
  • Cody Plasterer
  • Craig D Shriver
  • Dana Murphy
  • Edith P. Mitchell
  • Hai Hu
  • Hallgeir Rui
  • Inna Chervoneva
  • Jeffrey A. Hooke
  • Jennifer E Smith
  • Jeremy Prokop
  • Michael J Flister
  • Paul Auer
  • Shirng-Wern Tsaih
  • Sophia Ran
  • Yunguang Sun

Organizations

  • National Institutes of Health
  • Uniformed Services University of the Health Sciences